Clinical Study

Treatment For Acute Hepatitis C Infection

Posted Date: Oct 26, 2021

  • Investigator: Kenneth Sherman
  • Specialties:
  • Type of Study: Drug

the safety and success (efficacy) of treating people with acute hepatitis C with oral medications Glecaprevir/Pibrentasvir (Mavyret) for 8 weeks


Adult Weighing At Least 45Kg (99Lbs), Must Have Evidence Of Acute Hepatitis C (Hcv) Infection By Lab Reports Or Clinical Signs And Symptoms Within A Certain Time Period, Able To Take Pills, Will Attend All Study Visits.



For More Information:

Elizabeth Stambrook

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.